Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 96.90
+0.10 (0.10%)
Jun 25, 2026, 1:30 PM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 14.35 billion as of June 25, 2026. Its market cap has decreased by -27.96% in one year.
Market Cap
14.35B
Enterprise Value
12.30B
Revenue
10.28B
Ranking
n/a
PE Ratio
12.20
Stock Price
96.90
Market Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 14.35B, an increase of 518.05%. That is a compound annual growth rate of 5.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 14.35B | -23.40% |
| Dec 31, 2025 | 18.74B | -15.38% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 27.85B |
| TTY Biopharm Company | 18.38B |
| ScinoPharm Taiwan | 16.13B |
| Synmosa Biopharma | 15.47B |
| YungShin Global Holding | 15.24B |
| Handa Pharmaceuticals | 15.14B |
| Foresee Pharmaceuticals | 12.35B |
| Standard Chemical & Pharmaceutical | 11.19B |